WP
COLL icon

WealthPLAN Partners’s Collegium Pharmaceutical COLL Stock Holding History

WealthPLAN Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,482
Closed -$83.5K – 1283
2023
Q1 		$83.5K Buy
+3,482
New +$92.3K 0.01% 462

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

WealthPLAN Partners's COLL Position: Q2 2023 in Review

WealthPLAN Partners sold out of Collegium Pharmaceutical (COLL) in Q2 2023, closing a stake of 3,482 shares — an estimated $83.5K sold.

WealthPLAN Partners first reported a position in COLL in Q1 2023 and held it in 1 quarter. The position peaked at $83.5K in Q1 2023. 177 funds tracked by Wall St. Rank hold COLL as of Q2 2023.

  • WealthPLAN Partners reported no remaining Collegium Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 3,482 Collegium Pharmaceutical shares in Q2 2023, an estimated $83.5K.
  • WealthPLAN Partners first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 1 quarter.
  • WealthPLAN Partners's Collegium Pharmaceutical position peaked at $83.5K in Q1 2023.
  • 177 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2023.

Based on WealthPLAN Partners's 13F filing for Q2 2023, filed 31 Jul 2023.